Assessment of Tolerance of Mobilizing Peripheral Hematopoietic Stem Cells by Plerixafor in Sickle Cell Patients
Clinical trial NCT02212535 · COMPLETED
Trial details
- NCT number
- NCT02212535
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-15
- Primary completion
- 2017-04-04
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.